SCHEMBL997778

SCHEMBL997778

CCC(CC)(CC)C(=O)OC(CC(=O)O)(CC(=O)O)C(=O)O

nearest known ligand 0.37

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 2/20 0.37
HIF1A Q16665 2/20 0.37
CYP2D6 P10635 1/20 0.37
TSHR P16473 1/20 0.37
ALDH1A1 P00352 2/20 0.33
HMGCR P04035 1/20 0.33
CHRM1 P11229 1/20 0.33
TBXA2R P21731 1/20 0.33
ADRA1A P35348 1/20 0.33
CYP4F2 P78329 1/20 0.31
CYP4A11 Q02928 1/20 0.31
MEN1 O00255 1/20 0.31
CYP1A2 P05177 1/20 0.31
THRB P10828 1/20 0.31
KMT2A Q03164 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4731896 0.85 CYP2D6 (0.34) CYP2C19HIF1ACYP2D6TSHRALDH1A1
SCHEMBL167480 0.82 PAM (0.36) CYP2C19HIF1ACYP2D6TSHRALDH1A1
SCHEMBL4731097 0.79 CYP2C19 (0.44) CYP2C19HIF1ACYP2D6TSHRALDH1A1
SCHEMBL2404824 0.79 EPHX1 (0.39) TSHRALDH1A1MEN1KMT2A
SCHEMBL4731422 0.76 CYP2C19 (0.37) CYP2C19HIF1ACYP2D6TSHRALDH1A1
SCHEMBL11210956 0.76 ALDH1A1 (0.33) TSHRALDH1A1
SCHEMBL8068518 0.75 CYP2C19 (0.44) CYP2C19HIF1ACYP2D6TSHRALDH1A1
SCHEMBL1870019 0.75 CYP2C19 (0.39) CYP2C19HIF1ACYP2D6TSHRALDH1A1
SCHEMBL12485746 0.75 ALDH1A1 (0.52) CYP2C19HIF1ACYP2D6TSHRALDH1A1
SCHEMBL284431 0.74 CYP2C19 (0.42) CYP2C19HIF1ACYP2D6TSHRALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 187 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3932407-B1 ENTERIC COATED TABLET COMPOSITION COMPRISING TETRAMETHYLPYRAZINE NITRONE GUANGZHOU MAGPIE PHARMACEUTICALS CO LTD (CN) 2023-10-18 EP claimed
EP-4139387-A1 ADDITIVE COMPOSITION AND USE THEREOF, CONDENSATION POLYMER COMPOSITION, MOLDING COMPOUND AND MOLDING COMPOUNDS PRODUCED THEREFROM, AND MOLDED PARTS AND USE THEREOF Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) 2023-03-01 EP claimed
EP-4139385-A1 USE OF INORGANIC SULPHITES AND/OR THIOSULPHATES FOR STABILISING ALIPHATIC POLYESTERS, STABILISED MOULDING COMPOSITIONS AND MOULDING COMPOSITIONS AND MOULDED PARTS PRODUCED THEREFROM Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) 2023-03-01 EP claimed
EP-4139384-A1 ADDITIVE COMPOSITION AND USE THEREOF, CONDENSATION POLYMER COMPOSITION, MOLDING COMPOUND AND MOLDING COMPOUNDS PRODUCED THEREFROM, AND MOLDED PARTS AND USE THEREOF Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) 2023-03-01 EP claimed
EP-3003318-B1 USE OF SUSTAINED RELEASE DEXAMETHASONE IN POST-CATARACT SURGERY INFLAMMATION ICON BIOSCIENCE INC (US) 2021-12-22 EP claimed
EP-3911699-A1 USE OF AN ADDITIVE COMPOSITION FOR THE CONTROLLED ACCELERATED DECOMPOSITION OF CONDENSATION POLYMERS Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) 2021-11-24 EP claimed
WO-2021213939-A1 ADDITIVE COMPOSITION AND USE THEREOF, CONDENSATION POLYMER COMPOSITION, MOLDING COMPOUND AND MOLDING COMPOUNDS PRODUCED THEREFROM, AND MOLDED PARTS AND USE THEREOF Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) 2021-10-28 WO claimed
WO-2021213940-A1 USE OF INORGANIC SULPHITES AND/OR THIOSULPHATES FOR STABILISING ALIPHATIC POLYESTERS, STABILISED MOULDING COMPOSITIONS AND MOULDING COMPOSITIONS AND MOULDED PARTS PRODUCED THEREFROM Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) 2021-10-28 WO claimed
WO-2021213771-A1 ADDITIVE COMPOSITION AND USE THEREOF, CONDENSATION POLYMER COMPOSITION, MOLDING COMPOUND AND MOLDING COMPOUNDS PRODUCED THEREFROM, AND MOLDED PARTS AND USE THEREOF Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) 2021-10-28 WO claimed
EP-3513779-B1 COSMETIC COMPOSITION INCLUDING BIODEGRADABLE THERMOPLASTIC POLYMER PARTICLES, COSMETIC USE OF SAID PARTICLES AND COSMETIC TREATMENT METHOD CLARINS LAB (FR) 2020-07-29 EP claimed
EP-1360257-A1 CYANOACRYLATE COMPOSITIONS CURABLE TO FLEXIBLE POLYMERIC MATERIALS Loctite (R & D) Limited (IE) 2003-11-12 EP claimed
EP-0725789-B1 METHOD OF OBTAINING IMMUNOGLOBULINS FROM COLOSTRUM AND THEIR USE IN PHARMACEUTICAL COMPOSITION ANADIS LTD (AU) 2003-03-19 EP claimed
WO-2002053666-A1 CYANOACRYLATE COMPOSITIONS CURABLE TO FLEXIBLE POLYMERIC MATERIALS LOCTITE (R & D) LIMITED (IE) 2002-07-11 WO claimed
EP-0894490-B1 Cosmetic compositions comprising a film-forming polymer OREAL (FR) 2002-01-16 EP claimed
WO-2001074986-A1 LIQUID WASHING AGENTS CONTAINING POLYAMIDE HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2001-10-11 WO claimed
WO-2001066685-A1 NON-LIQUID WASHING AGENTS HAVING LIQUID BLEACH ACTIVATORS HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2001-09-13 WO claimed
EP-1059328-A1 One-component polyurethane foam compositions with improved curing behaviour HILTI Aktiengesellschaft (LI) 2000-12-13 EP claimed
EP-0609961-B1 Sustained release pharmaceutical composition FAULDING F H & CO LTD (AU) 1998-06-24 EP claimed
EP-0633896-B1 ESTERIFIED STARCH COMPOSITION NAT STARCH CHEM INVEST (US) 1998-06-17 EP claimed
EP-0377518-B1 Sustained release pharmaceutical composition FAULDING F H & CO LTD (AU) 1996-02-07 EP claimed